Clinical Trial Detail

NCT ID NCT03739710
Title Phase II Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Non-small Cell Lung Cancer (NSCLC)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

lung non-small cell carcinoma

Therapies

Docetaxel

Docetaxel + GSK3359609

Age Groups: adult senior

No variant requirements are available.